A retrospective, safety and efficacy study of Sofosbuvir/Velpatasvir/Voxilaprevir treatment in post‐liver transplant patients
Latest Information Update: 24 Feb 2020
At a glance
- Drugs Sofosbuvir/velpatasvir/voxilaprevir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 24 Feb 2020 New trial record